Login

Financial Snapshot

Revenue
TTM
$545.8M
Gross Margin
TTM
15.08%
Net Income
TTM
-$42.43M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
147.27%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
-$16.29M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$25.73M

Stock Price

Loading...
Market Cap: $458.92 Million

About Oncology Institute Inc

The Oncology Institute, Inc. (NASDAQ: TOI) is a value-based oncology company that operates a network of outpatient cancer care clinics through affiliated physician corporations (the TOI PCs). Revenue comes from two primary streams: capitation payments under managed care contracts, where TOI receives fixed per-member-per-month fees to manage oncology care for defined patient populations, and fee-for-service (FFS) billings to third-party payors including Medicare, Medicaid, commercial insurers, and patients for specific medical services rendered. Drug purchases, covering both oral and chemotherapy drugs, represented approximately 84% of total costs for the year ended December 31, 2025. As of December 31, 2025, TOI operated leases for 65 clinics across California, Arizona, Nevada, Florida, and Oregon, with principal executive offices in Cerritos, California. The company functions as a management services organization, providing administrative, billing, technology, and operational support to the TOI PCs under management services agreements.

Revenue model
Two revenue streams: capitation contracts (fixed per-member-per-month payments from managed care payors for delegated oncology care management) and fee-for-service billings to Medicare, Medicaid, commercial insurers, and patients for individual medical services rendered by TOI PC physicians. FFS revenue is recorded net of contractual adjustment allowances.
Products and services
Outpatient oncology care services including chemotherapy administration, oral oncology drug dispensing, specialty pharmacy operations, and physician-delivered cancer treatment. Drug procurement (oral and chemotherapy drugs) represents approximately 84% of total costs as of FY2025.
Customers and end markets
Cancer patients served through managed care and government payor contracts. Payors include Medicare, Medicaid, and commercial managed care organizations. FFS referral volume depends on relationships with primary care physicians and associated medical groups.
Value-chain role
Management services organization supporting affiliated physician corporations. TOI provides administrative, billing, collections, technology, and professional services infrastructure. Clinics operate under a fully delegated capitation model with payor partners, with selective direct clinic build-out over time.
Geographic exposure
United States only. As of December 31, 2025, 65 clinic leases across California, Arizona, Nevada, Florida, and Oregon. Principal offices in Cerritos, California under a lease expiring December 31, 2027.

Source: SEC 10-K, filed 2026-03-12

Industry: Services-Offices & Clinics of Doctors of Medicine Peers: AlerisLife Inc. Brookdale Senior Living Inc Sonida Senior Living Inc HCA Healthcare Inc Community Health Systems Inc HANGER, INC. Joint Corp National Healthcare Corp Pennant Group Inc US Physical Therapy Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support